Video

Dr. David Albala on The Role of Robotic Surgery in Prostate Cancer

David Albala, MD, urologist and medical director, Associated Medical Professionals, spoke with OncLive about the role and benefits of robotic surgery in prostate cancer during the LUGPA Annual Meeting.

Robotic surgery has a firm implant in urological surgery, especially in oncology, with prostatectomy and cystectomy procedures, Albala says.

The benefits of robotic surgery for patients include a quicker recovery time, less pain, and less blood loss. The complications are also very similar to what is seen in open surgery.

Patients undergoing a prostatectomy via robotic surgery are typically out of the hospital in one week, Albala says.

Related Videos
Albert Grinshpun, MD, MSc, head, Breast Oncology Service, Shaare Zedek Medical Center
Erica L. Mayer, MD, MPH, director, clinical research, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School
Stephanie Graff, MD, and Chandler Park, FACP
Mariya Rozenblit, MD, assistant professor, medicine (medical oncology), Yale School of Medicine
Maxwell Lloyd, MD, clinical fellow, medicine, Department of Medicine, Beth Israel Deaconess Medical Center
Neil Iyengar, MD, and Chandler Park, MD, FACP
Azka Ali, MD, medical oncologist, Cleveland Clinic Taussig Cancer Institute
Rena Callahan, MD, and Chandler Park, MD, FACP
Hope S. Rugo, MD, FASCO, Winterhof Family Endowed Professor in Breast Cancer, professor, Department of Medicine (Hematology/Oncology), director, Breast Oncology and Clinical Trials Education; medical director, Cancer Infusion Services; the University of California San Francisco Helen Diller Family Comprehensive Cancer Center
Virginia Kaklamani, MD, DSc, professor, medicine, Division of Hematology-Medical Oncology, The University of Texas (UT) Health Science Center San Antonio; leader, breast cancer program, Mays Cancer Center, UT Health San Antonio MD Anderson Cancer Center